06:03 AM EDT, 10/29/2025 (MT Newswires) -- Eli Lilly ( LLY ) said late Tuesday that it collaborated with Nvidia ( NVDA ) to develop an artificial intelligence supercomputer.

The supercomputer will be the "most powerful" owned and operated by a pharmaceutical firm, the company said, adding that it will be equipped with Nvidia's ( NVDA ) DGX SuperPOD with DGX B300 systems.

Eli Lilly ( LLY ) said it intends to utilize the supercomputer to reduce development cycles and deliver medicines faster.

Shares of Eli Lilly ( LLY ) edged 0.2% higher in recent Wednesday premarket activity, while Nvidia's ( NVDA ) stock was up 3.1%.